Jason R. Gotlib on JAK Inhibitors for the Treatment of Myelofibrosis
Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.
Read More
Jason R. Gotlib Discusses MPN Research at Stanford
Jason R. Gotlib discusses the research being done at his institution. Gotlib is a 2015 MPN Hero in the category of Commitment to the Individual and is also an international leader in MPN research.